People who should avoid using Wegovy may include the following: Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Anyone with a known hypersensitivity or past allergic reaction to semaglutide or any ingredients in Wegovy Some individuals may need to use extra caution before using Wegovy, including the following: People with a history of pancreatitis People with Type 2 diabetes and a history of diabetic retinopathy People with a history of depression, suicidal thoughts, or other mental health challenges Pregnant people or those planning to become pregnant, as Wegovy could harm the unborn baby People who are breastfeeding, as its unknown whether Wegovy passes into breast milk
Springer Nature Switzerland AG: 2020
[1] [2] Taking more than the prescribed dose can lead to an exaggerated pharmacological response, primarily affecting gastrointestinal function and potentially blood glucose levels
Based on the limited research available we can see that documented BPC-157 side effects include [4]: Injection site injuries (redness, scarring, etc) Nausea Fatigue Sweating Light-headedness Research into BPC-157s long-term side effects is lacking, warranting further investigation
Anti-Inflammatory Benefits Reduces damaging cytokines that worsen CKD